Clinical efficacy and randomized clinical trials in dysphagia

Area of Science:

• Speech and Hearing Sciences
• Clinical Medicine
• Medical Research

Background:

• Current research on treatment efficacy for swallowing disorders lacks large-scale randomized multi-institutional trials.
• Dose-response trials, crucial for determining optimal treatment levels in dysphagia, are not yet available.
• Financial and medical pressures on clinicians impact the timely diagnosis and treatment of dysphagia.

Purpose of the Study:

• To review the current state of research on treatment efficacy for swallowing disorders.
• To highlight the need for large-scale randomized multi-institutional trials in dysphagia research.
• To describe the integration of treatment techniques into diagnostic studies for rapid patient improvement.

Main Methods:

• Review of current literature on swallowing disorder treatment efficacy.
• Discussion of the challenges in conducting clinical trials for dysphagia.
• Description of the integration of treatment into diagnostic procedures like Modified Barium Swallow (videofluoroscopy).

Main Results:

• There is a significant gap in dose-response data for dysphagia treatments.
• Clinical pressures can compromise the ideal timing of patient care.
• The integration of treatment into diagnostic studies is a strategy for immediate patient benefit.

Conclusions:

• The field requires more robust clinical trials, particularly dose-response studies, to advance dysphagia treatment.
• Addressing clinical pressures and facilitating research are essential for improving patient outcomes.
• The Communications Sciences and Disorders Clinical Trials Research Group (CSDRG) is available to support clinical trial development in dysphagia.